Literature DB >> 12161442

Fatty acid regulation of liver X receptors (LXR) and peroxisome proliferator-activated receptor alpha (PPARalpha ) in HEK293 cells.

Anjali Pawar1, Jinghua Xu, Erik Jerks, David J Mangelsdorf, Donald B Jump.   

Abstract

Fatty acids bind to and regulate the activity of peroxisome proliferator-activated (PPAR) and liver X receptors (LXR). However, the role lipid metabolism plays in the control of intracellular fatty acid ligands is poorly understood. We have identified two strains of HEK293 cells that display differences in fatty acid regulation of nuclear receptors. Using full-length and Gal4-LBD chimeric receptors in functional assays, 20:4,n6 induced PPARalpha activity approximately 2.2-fold and suppressed LXRalpha activity by 80% (ED50 approximately 25-50 microm) in HEK293-E (early passage) cells but had no effect on PPARalpha or LXRalpha receptor activity in HEK293-L (late passage) cells. LXRbeta was insensitive to fatty acid regulation in both HEK293 strains. Metabolic labeling studies using [14C]20:4,n6 (at 100 microm) indicated that the uptake of 20:4,n6 and its assimilation into triacylglycerol, diacylglycerol, and polar lipids revealed no difference between the two strains. Such treatment increased total cellular 20:4,n6 ( approximately 11-fold) and its elongation product, 22:4,n6 ( approximately 3.6-fold), within 6 h. Non-esterified 20:4,n6 and 22:4,n6 represented <or=3% of the total cellular 20:4,n6 and 22:4,n6. In HEK293-E cells, non-esterified 20:4,n6 and 22:4,n6 increased 8- and 18-fold, respectively, by 6 h and was sustained at that level for 24 h. In HEK293-L cells, non-esterified 20:4,n6 also increased (5-fold) at 6 h but fell by 70% within 24 h. In contrast to HEK293-E cells, non-esterified 22:4,n6 did not accumulate in HEK293-L cells. Functional assays showed that 22:4,n6 was approximately 2-fold more effective than 20:4,n6 at inhibiting oxysterol-induced LXRalpha activity in HEK293-E cells, but had no effect on LXRalpha activity in HEK293-L cells. Taken together, these findings demonstrate that the rate of assimilation of exogenously added fatty acids and their metabolites into complex lipids plays an important role in regulating PPARalpha and LXRalpha activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161442     DOI: 10.1074/jbc.M206170200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases.

Authors:  Yun Wang; Daniela Botolin; Barbara Christian; Julia Busik; Jinghua Xu; Donald B Jump
Journal:  J Lipid Res       Date:  2005-01-16       Impact factor: 5.922

2.  Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways.

Authors:  Daniela Botolin; Yun Wang; Barbara Christian; Donald B Jump
Journal:  J Lipid Res       Date:  2005-10-12       Impact factor: 5.922

Review 3.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

4.  A defect in Δ6 and Δ5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2010-11-09       Impact factor: 3.876

5.  Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression.

Authors:  Jong Bae Seo; Hyang Mi Moon; Woo Sik Kim; Yun Sok Lee; Hyun Woo Jeong; Eung Jae Yoo; Jungyeob Ham; Heonjoong Kang; Myoung-Gyu Park; Knut R Steffensen; Thomas M Stulnig; Jan-Ake Gustafsson; Sang Dai Park; Jae Bum Kim
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

6.  Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.

Authors:  So Young Bu; Mara T Mashek; Douglas G Mashek
Journal:  J Biol Chem       Date:  2009-09-08       Impact factor: 5.157

7.  Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition.

Authors:  Yun Wang; Moises Torres-Gonzalez; Sasmita Tripathy; Daniela Botolin; Barbara Christian; Donald B Jump
Journal:  J Lipid Res       Date:  2008-03-30       Impact factor: 5.922

8.  Microglial cell activation increases saturated and decreases monounsaturated fatty acid content, but both lipid species are proinflammatory.

Authors:  Emily B Button; Andrew S Mitchell; Marcia M Domingos; Jessica H-J Chung; Ryan M Bradley; Ashkan Hashemi; Phillip M Marvyn; Ashley C Patterson; Ken D Stark; Joe Quadrilatero; Robin E Duncan
Journal:  Lipids       Date:  2014-01-29       Impact factor: 1.880

9.  Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.

Authors:  Yun Wang; Daniela Botolin; Jinghua Xu; Barbara Christian; Ernestine Mitchell; Bolleddula Jayaprakasam; Muraleedharan G Nair; Muraleedharan Nair; Jeffrey M Peters; Jeffery M Peters; Julia V Busik; Julia Busik; L Karl Olson; Donald B Jump
Journal:  J Lipid Res       Date:  2006-06-21       Impact factor: 5.922

10.  Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.

Authors:  Christopher D Green; Donald B Jump; L Karl Olson
Journal:  Endocrinology       Date:  2009-02-19       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.